Thursday 30 October 2008

Buy Colgate, target of Rs 432: India Infoline

India Infoline has maintained its buy rating on Colgate Palmolive (India) with a target of Rs 432 in its October 27, 2008 research report. "Colgate recorded 13.4% yoy growth in revenues at Rs 4.13 billion during Q2 FY09, marginally below our expectations of Rs 4.2 billion led by overall volume growth of 11.1% yoy. Aided by higher income (Rs 270 million against Rs 199 millionn during Q2 FY08) and sharp decline in the effective tax rate (11.9% against 22.4% in same quarter last year), net profit rose by 16% yoy to Rs 635 million (below our expectations of Rs 698 million)."

"Colgate dominates the oral care industry with a strong 50% market share. After a healthy 10% growth in FY08, we expect Colgate to continue industry outperformance in FY09 (Industry growth expected 10%). With successful new launches and re-launches coupled with the fiscal benefits from the Baddi plant, we expect Colgate to witness revenue and profit CAGR of 11.9% and 17.5% respectively over the next two years. At the current market price of Rs 382, the stock is trading at 16.2x FY10E EPS of Rs 23.6. We maintain Buy with a price target of Rs 432, an upside of 13.3%," says India Infoline's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Source: Moneycontrol

No comments:

Post a Comment

DISCLAIMER: The author is not a registered stockbroker nor a registered advisor and does not give investment advice. His comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to buy or sell a stock, option, future, bond, commodity, index or any other financial instrument at any time. While he believes his statements to be true, they always depend on the reliability of his own credible sources. The author recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction, before making any investment decisions, and that you confirm the facts on your own before making important investment commitments.